|
Premium Company Profile - Endo Pharmaceuticals (Datamonitor)
Market: Healthcare and Medical
Published Date: 27/11/2007
Market Research Report Title: Premium Company Profile - Endo Pharmaceuticals
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 58
|
Enquire about Report |
Summary: Introduction
Endo Pharmaceuticals′ main focus is to develop and market prescription drugs for pain management. The company′s marketed product, Lidoderm, indicated for the relief of pain associated with post-herpetic neuralgia, has been the major contributor to its revenues. Further, the company′s acquisition of RxKinetix in 2006 provided an expansion of the company into therapeutic areas.
Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals. The company has a portfolio of branded products that includes: Lidoderm, Percocet, Frova, Percodan, Opana, Opana ER and Synera.The company′s lead product candidate EN 3285 Oral Rinse for treating Oral mucositis is currently in Phase 2 clinical trials. In addition, Endo Pharmaceuticals has two licensed products in Phase 3 namely: topical ketoprofen patch and rapinyl used for treating pain associated with soft tissue injuries and cancer, respectively.Endo Pharmaceuticals derives its revenues from product sales of its proprietary and in-licensed products. The company′s total revenues increased at a CAGR of 10.9% during 2002-2006, from $399 million to $909.7 million. This represents an absolute total growth of +$510 million for total revenues.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company′s strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company′s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
